Taiwan FDA registration 416f2b4b0986fe40947df06a74c8c7e0
Daisling Lyasan Toxoplasma immunoglobulin G detection reagent and quality control group
TW: 戴思林禮亞尚弓漿蟲免疫球蛋白G檢測試劑及品管組
Taiwan·Risk Class 2·DIASORIN S.P.A.·Registered Feb 06, 2007 – Feb 06, 2012CancelledRegistration details
- Analysis ID
- 416f2b4b0986fe40947df06a74c8c7e0
- Customs Code
- DHA00601790600
Company information
- Manufacturer
- DIASORIN S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- Chemical cold light immunoassay (CLIA) is used to quantitatively determine Toxoplasma-specific immunoglobulin G antibodies in human serum or plasma samples.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3780 弓漿蟲血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Feb 06, 2007
- Expiry Date
- Feb 06, 2012
- Cancellation Date
- Apr 03, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Daisling Lyasan Toxoplasma immunoglobulin G detection reagent and quality control group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 416f2b4b0986fe40947df06a74c8c7e0 and manufactured by DIASORIN S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices